Cabaletta Bio, Inc. (CABA)

Cabaletta Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	20.79	19.24	14.84	13.82	12.46	7.01
Research & Development	64.94	55.42	39.3	32.49	21.38	11.67
Operating Expenses	85.74	74.66	54.14	46.31	33.83	18.68
Operating Income	-85.74	-74.66	-54.14	-46.31	-33.83	-18.68
Other Expense / Income	-8.87	-6.99	-1.16	-0.02	-0.49	-1.74
Pretax Income	-76.87	-67.68	-52.98	-46.29	-33.34	-16.94
Net Income	-76.87	-67.68	-52.98	-46.29	-33.34	-16.94
Preferred Dividends	0	0	0	0	0	5.33
Net Income Common	-76.87	-67.68	-52.98	-46.29	-33.34	-22.27
Shares Outstanding (Basic)	48	43	29	28	24	24
Shares Change	53.92%	47.69%	2.41%	17.78%	0.09%	1253.67%
EPS (Basic)	-1.72	-1.65	-1.81	-1.80	-1.44	-4.07
EPS (Diluted)	-1.72	-1.65	-1.81	-1.80	-1.44	-4.07
Free Cash Flow	-66.05	-54.24	-48.83	-35.28	-27.41	-16.74
Free Cash Flow Per Share	-1.37	-1.27	-1.68	-1.25	-1.14	-0.70
EBITDA	-72.37	-64.18	-49.29	-45.56	-32.99	-16.84
Depreciation & Amortization	4.5	3.5	3.68	0.73	0.35	0.1
EBIT	-76.87	-67.68	-52.98	-46.29	-33.34	-16.94

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).